Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
26
0.580
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1031
0.500
 Why?
Leukemia, Myeloid, Acute
4
2010
203
0.390
 Why?
Osteosarcoma
2
2016
44
0.330
 Why?
von Willebrand Diseases
1
2009
25
0.310
 Why?
Hematology
1
2009
28
0.310
 Why?
Sclerotherapy
2
2020
46
0.310
 Why?
Antineoplastic Agents
5
2016
1222
0.290
 Why?
Vascular Malformations
2
2020
103
0.280
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.280
 Why?
Hemophilia B
1
2007
5
0.270
 Why?
Hemostasis, Surgical
1
2007
12
0.270
 Why?
Blood Coagulation Factors
1
2007
17
0.270
 Why?
Enoxaparin
1
2007
31
0.270
 Why?
Blood Loss, Surgical
1
2007
71
0.260
 Why?
Child, Preschool
13
2020
4076
0.260
 Why?
Venous Thrombosis
1
2007
90
0.250
 Why?
Cisplatin
3
2016
285
0.250
 Why?
Cyclosporine
1
2005
67
0.240
 Why?
Blood Coagulation Disorders
2
2020
40
0.240
 Why?
Leukemia
1
2005
67
0.230
 Why?
Hemostasis
2
2020
60
0.230
 Why?
Cladribine
1
2004
3
0.230
 Why?
Bone Regeneration
2
2016
70
0.220
 Why?
Histiocytosis, Langerhans-Cell
1
2004
33
0.220
 Why?
Retinoblastoma
1
2003
15
0.210
 Why?
Retinal Neoplasms
1
2003
13
0.210
 Why?
Infant
11
2018
3733
0.210
 Why?
Neoplasms
3
2012
1325
0.200
 Why?
Neoplasms, Second Primary
1
2003
77
0.200
 Why?
Child
14
2020
7248
0.190
 Why?
Bone Neoplasms
1
2003
184
0.180
 Why?
Thrombelastography
1
2020
26
0.170
 Why?
Adolescent
11
2020
6739
0.170
 Why?
Bleomycin
1
2018
38
0.140
 Why?
Down Syndrome
3
2008
93
0.140
 Why?
Antibiotics, Antineoplastic
1
2018
80
0.140
 Why?
Osteogenesis, Distraction
2
2016
78
0.130
 Why?
Piperazines
2
2016
118
0.130
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.130
 Why?
Leukemia, Myeloid
2
2008
42
0.130
 Why?
Humans
21
2020
52483
0.120
 Why?
Disease-Free Survival
5
2010
460
0.120
 Why?
Imidazoles
1
2016
124
0.120
 Why?
Remission Induction
4
2011
218
0.120
 Why?
Male
13
2020
26761
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
91
0.120
 Why?
Leukocyte Count
2
2005
73
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
39
0.110
 Why?
Survival Analysis
4
2010
673
0.100
 Why?
Doxorubicin
2
2005
241
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
9
0.090
 Why?
Sarcoma, Myeloid
1
2011
20
0.090
 Why?
Neutropenia
1
2012
115
0.090
 Why?
Heart Neoplasms
1
2011
32
0.090
 Why?
Treatment Outcome
7
2018
5422
0.090
 Why?
Core Binding Factors
1
2010
3
0.080
 Why?
Proto-Oncogene Proteins c-kit
1
2010
33
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Listeriosis
1
2009
7
0.080
 Why?
Female
10
2020
28171
0.080
 Why?
Anemia, Aplastic
1
2009
11
0.080
 Why?
Platelet Transfusion
1
2009
33
0.080
 Why?
Histocompatibility Testing
1
2008
15
0.080
 Why?
Acute Lung Injury
1
2009
28
0.080
 Why?
HLA Antigens
1
2008
56
0.070
 Why?
Abdominal Pain
1
2009
85
0.070
 Why?
Young Adult
5
2020
4329
0.070
 Why?
Bone Marrow Transplantation
1
2008
113
0.070
 Why?
Hospitals, Pediatric
1
2009
243
0.070
 Why?
Retrospective Studies
6
2018
6607
0.070
 Why?
Adult
7
2020
14161
0.070
 Why?
Infusions, Intravenous
2
2004
220
0.070
 Why?
Cardiomyopathies
1
2008
121
0.070
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
78
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
857
0.060
 Why?
Tamoxifen
1
2005
60
0.060
 Why?
Heart
1
2008
345
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.060
 Why?
Proto-Oncogene Proteins
1
2004
151
0.050
 Why?
Immunosuppressive Agents
1
2005
243
0.050
 Why?
Humerus
1
2003
16
0.050
 Why?
Arkansas
1
2009
2028
0.050
 Why?
Tibia
1
2003
113
0.050
 Why?
Methotrexate
1
2003
77
0.050
 Why?
Mutation
2
2010
1347
0.050
 Why?
Survivors
1
2003
120
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
18
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
399
0.040
 Why?
Blood Coagulation Tests
1
2020
20
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1378
0.040
 Why?
Blood Flow Velocity
1
2020
95
0.040
 Why?
Blood Coagulation
1
2020
64
0.040
 Why?
Follow-Up Studies
2
2018
2279
0.040
 Why?
Prognosis
3
2012
2099
0.040
 Why?
Mice, Inbred C57BL
2
2016
1884
0.040
 Why?
Gene Expression Profiling
1
2004
1105
0.040
 Why?
Hemorrhage
1
2020
209
0.040
 Why?
Daunorubicin
2
2008
13
0.030
 Why?
Cytarabine
2
2006
42
0.030
 Why?
Mice, Nude
1
2016
265
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
220
0.030
 Why?
Random Allocation
1
2016
285
0.030
 Why?
Acute Disease
2
2008
373
0.030
 Why?
Cluster Analysis
2
2005
233
0.030
 Why?
Prospective Studies
2
2012
2481
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
405
0.030
 Why?
Interleukin-3
1
2012
12
0.020
 Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.020
 Why?
Protein Precursors
1
2012
42
0.020
 Why?
Calcitonin
1
2012
30
0.020
 Why?
Sensitivity and Specificity
2
2006
891
0.020
 Why?
Interleukin-8
1
2012
86
0.020
 Why?
Interleukin-10
1
2012
84
0.020
 Why?
ROC Curve
1
2012
253
0.020
 Why?
Fatal Outcome
1
2011
197
0.020
 Why?
Mice, Knockout
1
2013
879
0.020
 Why?
Interleukin-6
1
2012
278
0.020
 Why?
Intensive Care Units
1
2012
243
0.020
 Why?
Pilot Projects
1
2012
721
0.020
 Why?
Exons
1
2010
102
0.020
 Why?
Animals
2
2016
13505
0.020
 Why?
Time Factors
2
2008
2968
0.020
 Why?
Opportunistic Infections
1
2009
56
0.020
 Why?
Echocardiography
1
2011
415
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Translocation, Genetic
1
2010
265
0.020
 Why?
Proportional Hazards Models
1
2008
443
0.020
 Why?
Hospitalization
1
2012
736
0.020
 Why?
Recurrence
1
2008
672
0.020
 Why?
Genetic Predisposition to Disease
1
2010
528
0.020
 Why?
Prevalence
1
2010
1006
0.020
 Why?
Immunophenotyping
1
2006
117
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1165
0.020
 Why?
Luciferases
1
2005
48
0.020
 Why?
Nucleic Acid Hybridization
1
2005
56
0.020
 Why?
Cell Membrane
1
2006
245
0.020
 Why?
Diagnosis, Differential
1
2009
1046
0.020
 Why?
DNA Primers
1
2005
208
0.020
 Why?
Middle Aged
1
2020
13028
0.010
 Why?
Transfection
1
2005
357
0.010
 Why?
Tumor Cells, Cultured
1
2005
460
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
20
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
582
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1546
0.010
 Why?
Benzamides
1
2004
50
0.010
 Why?
Risk Assessment
1
2008
1327
0.010
 Why?
Risk Factors
1
2012
3889
0.010
 Why?
Mice
1
2013
5949
0.010
 Why?
Pyrimidines
1
2004
199
0.010
 Why?
Nuclear Proteins
1
2004
245
0.010
 Why?
DNA Helicases
1
2004
150
0.010
 Why?
DNA-Binding Proteins
1
2004
422
0.010
 Why?
Predictive Value of Tests
1
2004
944
0.010
 Why?
Drug Administration Schedule
1
2002
374
0.010
 Why?
Linear Models
1
2002
287
0.010
 Why?
Transcription Factors
1
2004
566
0.010
 Why?
Neutrophils
1
2002
147
0.010
 Why?
Analysis of Variance
1
2002
554
0.010
 Why?
Patient Selection
1
2002
259
0.010
 Why?
Infant, Newborn
1
2006
2867
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department